Aequalis Reversed II
Device Trauma & Extremities
PDI 03700386932656
General payments
$233,384
Research payments
$63,745
Through program year 2025, $233,384 in general payments and $63,745 in research payments were reported against Aequalis Reversed II (Trauma & Extremities).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $1,111 | 9 |
| 2024 | General | $24,366 | 17 |
| 2024 | Research | $37,003 | 5 |
| 2023 | General | $197,755 | 124 |
| 2023 | Research | $12,222 | 4 |
| 2022 | General | $9,736 | 14 |
| 2022 | Research | $14,520 | 6 |
| 2021 | General | $415 | 11 |
Breakdown
The top 5 of 9 recipients; each share is of general payments naming this product in 2025.
Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 7 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
175 general · 15 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.